Edition:
United Kingdom

CSPC Pharmaceutical Group Ltd (1093.HK)

1093.HK on Hong Kong Stock

19.12HKD
8:20am BST
Change (% chg)

HK$-0.88 (-4.40%)
Prev Close
HK$20.00
Open
HK$20.25
Day's High
HK$20.25
Day's Low
HK$18.90
Volume
30,256,244
Avg. Vol
35,760,974
52-wk High
HK$26.75
52-wk Low
HK$11.88

Select another date:

Wed, Apr 18 2018

BRIEF-CSPC Pharmaceutical Announces A Product Licensing Agreement

* UNIT ENTERED PRODUCT LICENSING AGREEMENT WITH GALAXY BIO, INC. FOR LICENSING & COMMERCIALIZATION OF "PACLITAXEL FOR INJECTION"

BRIEF-CSPC Pharmaceutical Group Says Cancer Drug Approved By China FDA

* "VINORELBINE TARTRATE LIPOSOME INJECTION" GRANTED CLINICAL TRIAL APPROVAL BY CHINA FOOD AND DRUG ADMINISTRATION OF PRC Source text for Eikon: Further company coverage:

BRIEF-CSPC Pharmaceutical Group's Drug Gets Approval By China FDA

* GRANTED APPROVAL BY CHINA FDA FOR PASSING CONSISTENCY OF QUALITY AND EFFICACY EVALUATION OF GENERIC DRUGS

BRIEF-CSPC Pharmaceutical Group Says ‍Cancer Drug Granted Drug Clinical Trial Approval By China FDA

* ‍CANCER DRUG DEVELOPED BY WUHAN YZY BIOPHARMA​ GRANTED DRUG CLINICAL TRIAL APPROVAL BY CHINA FDA Source text for Eikon: Further company coverage:

Select another date: